View More Recent Stories

Apr 17, 2025 09:41AM Piper Sandler on Procept BioRobotics Corp (PRCT): 'Compelling Setup Ahead of Near-Term Catalysts'
Apr 3, 2025 09:50AM TD Cowen on Medical Supplies & Devices: 'Companies Least Affected by New Reciprocal Tariffs'
Mar 24, 2025 08:02AM PROCEPT BioRobotic (PRCT): WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
Mar 4, 2025 06:36AM Jefferies Reiterates Hold Rating on Procept BioRobotics Corp (PRCT)
Feb 25, 2025 04:31PM PROCEPT BioRobotics Corporation (PRCT) Misses Q4 EPS by 1c
Jan 21, 2025 06:00PM MedTech sector outlook for 2025: Truist Securities
Jan 16, 2025 09:04AM Spruce Point short PROCEPT BioRobotics Corporation (PRCT)
Jan 16, 2025 09:03AM PROCEPT BioRobotics Corporation (PRCT) Mentioned as Short at Spruce Point
Jan 16, 2025 09:02AM Spruce Point short PROCEPT BioRobotics Corporation (PRCT)
Dec 19, 2024 08:17AM Medical Technology and Devices: Piper Sandler Shares 'Quick Thoughts on HC Conference in Jan'
Dec 2, 2024 06:03AM Morgan Stanley Starts Procept BioRobotics Corp (PRCT) at Overweight, PT $105
Nov 14, 2024 05:18AM Jefferies Starts Procept BioRobotics Corp (PRCT) at Hold
Oct 30, 2024 06:06AM PROCEPT BioRobotics Corporation (PRCT) Prices 1.92M Share Offering at $91/sh
Oct 29, 2024 10:38AM Procept BioRobotics Corp (PRCT) PT Raised to $105 at Truist Securities
Oct 29, 2024 05:49AM BTIG Reiterates Neutral Rating on Procept BioRobotics Corp (PRCT)
Oct 28, 2024 04:19PM PROCEPT BioRobotics Corporation (PRCT) Announces Proposed $175M Share Offering
Oct 28, 2024 01:51PM PROCEPT BioRobotics Corporation (PRCT) November 70 and December 90 calls active as share price up 27%
Oct 28, 2024 07:08AM PROCEPT BioRobotics Corporation (PRCT) Tops Q3 EPS by 9c
Oct 8, 2024 08:11AM TD Cowen Reiterates Buy Rating on Procept BioRobotics Corp (PRCT)
Oct 8, 2024 07:30AM Piper Sandler Reiterates Overweight Rating on Procept BioRobotics Corp (PRCT)
Oct 7, 2024 04:04PM PROCEPT BioRobotics (PRCT) Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer
Sep 16, 2024 08:58AM Procept BioRobotics Corp (PRCT) PT Raised to $99 at TD Cowen
Sep 3, 2024 06:02AM Procept BioRobotics Corp (PRCT) PT Raised to $95 at Truist Securities
Aug 22, 2024 05:36AM Procept BioRobotics Corp (PRCT) PT Raised to $94 at BofA Securities
Aug 21, 2024 11:14AM TD Cowen Reiterates Buy Rating on Procept BioRobotics Corp (PRCT)
Aug 21, 2024 11:11AM Truist Securities Reiterates Buy Rating on Procept BioRobotics Corp (PRCT)
Aug 21, 2024 07:02AM PROCEPT BioRobotics Corporation (PRCT) Announces FDA Clearance of the HYDROS Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy
Aug 1, 2024 05:12PM PROCEPT BioRobotics Corporation (PRCT) Tops Q2 EPS by 2c
Jul 29, 2024 03:10PM PROCEPT BioRobotics Corporation (PRCT) August 55, 60 and 65 puts active
Jul 16, 2024 07:47AM Procept BioRobotics Corp (PRCT) PT Raised to $79 at Truist Securities
Jul 2, 2024 10:21AM TD Cowen Reiterates Buy Rating on Procept BioRobotics Corp (PRCT)
Jun 17, 2024 04:03PM PROCEPT BioRobotics (PRCT) Announces New CPT Category I Code from the American Medical Association for Aquablation therapy
Apr 13, 2024 08:00AM Analyst weighs in on current investor sentiment in MedTech sector
Mar 27, 2024 10:00AM Top 4 AI robotics stocks set to soar (Part 3)
View More Recent Stories